- Effect of Fenofibrate and Exercise on Metabolic Syndrome and Hepatic Steatosis
-
Cha BS, Lee JH
- KMID: 1512030
- J Korean Endocr Soc.
- 2007 Jun;22(3):188-191.
- doi: 10.3803/jkes.2007.22.3.188
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Fenofibrate Therapy on Blood Creatinine Levels in Patients with Hypertension and Hypertriglyceridemia
-
Cho JH, Choi YH, Hyeon CW, Kim KJ, Hyun S, Kwon JE, Kim EY, Lee WS, Lee KJ, Kim SW, Kim TH, Kim CJ
- KMID: 2095091
- J Lipid Atheroscler.
- 2013 Jun;2(1):19-26.
- doi: 10.12997/jla.2013.2.1.19
OBJECTIVE: Previous studies have reported that fenofibrate therapy increased blood creatinine levels. We investigated the effect of fenofibrate therapy on creatinine levels in patients with hypertension and hypertriglyceridemia. METHODS: This retrospective... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Long-term Fenofibrate Therapy on Serum Creatinine and Its Reversibility in Hypertriglyceridemic Patients with Hypertension
-
Park GT, Jung M, Kim Y, Cho I, Won H, Shin SY, Lee WS, Lee KJ, Kim SW, Kim TH, Kim CJ
- KMID: 2401111
- J Lipid Atheroscler.
- 2017 Dec;6(2):89-96.
- doi: 10.12997/jla.2017.6.2.89
OBJECTIVE: Previous studies have shown that fenofibrate therapy increases serum creatinine level and that there is a return of serum creatinine to baseline level after the discontinuation of the drug.... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Short-term Fenofibrate Therapy on Blood Creatinine Levels in Patients with Hypertriglyceridemia
-
Hyeon CW, Choi YH, Hyun S, Kwon JE, Kim EY, Shin SY, Lee WS, Lee KJ, Kim SW, Kim TH, Kim CJ
- KMID: 2269334
- Korean J Med.
- 2014 Jun;86(6):702-709.
BACKGROUND/AIMS: Previous studies have reported that fenofibrate therapy increases blood creatinine levels. The aim of this study was to evaluate the effect of fenofibrate therapy on the renal function in... -
- CITED
-
- Close
- SHARE
-
- Close
- Fenofibrate Reduces C-Reactive Protein Levels in Hypertriglyceridemic Patients With High Risks for Cardiovascular Diseases
-
Min YJ, Choi YH, Hyeon CW, Cho JH, Kim KJ, Kwon JE, Kim EY, Lee WS, Lee KJ, Kim SW, Kim TH, Kim CJ
- KMID: 2224973
- Korean Circ J.
- 2012 Nov;42(11):741-746.
- doi: 10.4070/kcj.2012.42.11.741
BACKGROUND AND OBJECTIVES: The effects of fenofibrate on C-reactive protein (CRP) are under debate. We investigated the effect of fenofibrate on CRP levels and the variables determining changes. SUBJECTS AND METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
- Fenofibrate Therapy and Change of Renal Function: Management, What and How?
-
Kim SH
- KMID: 2269333
- Korean J Med.
- 2014 Jun;86(6):698-701.
Fenofibrate is one of PPAR-alpha (peroxisome proliferator activated receptor alpha) agonists. Fenofibrate decreases effectively triglyceride and increases high density lipoprotein cholesterol level through the effect on lipoprotein lipase, hepatic production... -
- CITED
-
- Close
- SHARE
-
- Close
- Exercise and Fenofibrate Reduces Body Adiposity Synergistically in OLETF Rats
-
An YJ, Lee HJ, Park MK, Lee KI, Koh IY, Jung DS, Kang AY, Kim DK
- KMID: 2063414
- J Korean Diabetes Assoc.
- 2004 Apr;28(2):131-138.
BACKGROUND: The PPAR alpha activator, Fenofibrate, is a pharmacological ligand, which induces beta-oxidation of long chain fatty acids in the mitochondria of hepatocytes. The beta-oxidation induced by exogenous PPAR alpha... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of the combination of metformin and fenofibrate on glucose homeostasis in diabetic Goto-Kakizaki rats
-
Oh TJ, Shin JY, Kang GH, Park KS, Cho YM
- KMID: 2154249
- Exp Mol Med.
- 2013 Jul;45(7):e30.
Metformin has been reported to increase the expression of the glucagon-like peptide-1 (GLP-1) receptor in pancreatic beta cells in a peroxisome proliferator-activated receptor (PPAR)-alpha-dependent manner. We investigated whether a PPARalpha... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Fenofibrate Medication on Renal Function
-
Kim S, Ko K, Park S, Lee DR, Lee J
- KMID: 2390339
- Korean J Fam Med.
- 2017 Jul;38(4):192-198.
- doi: 10.4082/kjfm.2017.38.4.192
BACKGROUND: Fibrates are widely used to treat hypertriglyceridemia, a risk factor for arteriosclerosis, but these compounds have been associated with renal dysfunction. This study aimed to investigate the effects of... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of fenofibrate on C-reactive protein levels in hypertriglyceridemic patients
-
Lee SH, Lee KH, Choi YJ, Lee KH, Choi SH, Lee KE, Lee KJ, Kim TH, Ko HS, Kim CJ, Ryu WS
- KMID: 2305972
- Korean J Med.
- 2006 Jun;70(6):656-662.
BACKGROUND: High levels of C-reactive protein (CRP) are associated with an increased risk for cardiovascular diseases. Most reports on the effect of fibrate on CRP level have inadequate study designs... -
- CITED
-
- Close
- SHARE
-
- Close
- Regulatory Effects of Fenofibrate with Inflammatory Response and Myocardiac Dysfunction in Lipopolysaccharide-stimulated Heart Tissues
-
Song DH, Hwang Y, Yoo SJ
- KMID: 2333209
- J Korean Soc Emerg Med.
- 2012 Oct;23(5):721-729.
PURPOSE: This study was intended to establish experimental conditions for monitoring the cardioprotective effects of fenofibrate on cardiac function in lipopolysaccharide (LPS)-stimulated BalB/c mice. METHODS: To investigate the effects of fenofibrate... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Procetofene(Lipanthyl(R))on Serum Cholesterol and Triglyceride in Hyperlipidemic Patients
-
Choi IY, Kim IS, Lee CK
- KMID: 1668798
- Korean Circ J.
- 1986 Sep;16(3):389-394.
- doi: 10.4070/kcj.1986.16.3.389
We observed the serum cholesterol, triglyceride and HDL-cholesterol values in 25 hyperlipidemic patients with procectofene(LIpanthyl(R))administration. 1) The mean serum lipids before & after procetofene administration was as follows 2) The... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Xanthoma Disseminatum
-
Park TH, Kim SI, Yoo JH, Kim KJ
- KMID: 1568859
- Korean J Dermatol.
- 2000 Oct;38(10):1401-1403.
Xanthoma disseminatum is a rare disorder that is a distinct subset of cutaneous nonhistiocytosis X. We report a case of xanthoma disseminatum in a 52-year-old woman. She had yellow-brownish variable... -
- CITED
-
- Close
- SHARE
-
- Close
- Reduction of Food Intake by Fenofibrate is Associated with Cholecystokinin Release in Long-Evans Tokushima Rats
-
Park MK, Han Y, Kim MS, Seo E, Kang S, Park SY, Koh H, Kim DK, Lee HJ
- KMID: 1768011
- Korean J Physiol Pharmacol.
- 2012 Jun;16(3):181-186.
- doi: 10.4196/kjpp.2012.16.3.181
Fenofibrate is a selective peroxisome proliferator-activated receptor alpha (PPARalpha) activator and is prescribed to treat hyperlipidemia. The mechanism through which PPARalpha agonists reduce food intake, body weight, and adiposity remains... -
- CITED
-
- Close
- SHARE
-
- Close
- The effects on serum lipoprotein(a) of antihyperlipidemic agents
-
Kim KT, Park SJ, Suh YS, Kim DH, Shin DH
- KMID: 2295267
- J Korean Acad Fam Med.
- 2000 Feb;21(2):234-243.
BACKGROUND: Many studies to reduce serum lipoprotein(a) are done because serum lipoprotein(a) has been known to be an independent risk factor of coronary artery disease along with age, smoking, diabetes,... -
- CITED
-
- Close
- SHARE
-
- Close
- Neither polyphenol-rich red wine nor fenofibrate affects the onset of type-1 diabetes mellitus in the BB rat
-
Ã…vall K, Berggren P, Juntti-Berggren L
- KMID: 2420825
- Lab Anim Res.
- 2018 Sep;34(3):126-131.
- doi: 10.5625/lar.2018.34.3.126
Serum levels of the pro-inflammatory apolipoprotein CIII (apoCIII) are increased in type-1 diabetic (T1D) patients and when β-cells are exposed to apoCIII they undergo apoptosis, which can be prevented by... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effect of Fenofibrate and Exercise on Metabolic Syndrome and Hepatic Steatosis in OLETF Rats
-
Lee KI, Kim JM, Park JY, Kim JW, Mok JY, Park MK, Lee HJ, Hong SH, Li W, Kim DK
- KMID: 1512031
- J Korean Endocr Soc.
- 2007 Jun;22(3):192-202.
- doi: 10.3803/jkes.2007.22.3.192
BACKGROUND: The aim of this study is to verify the effects of fenofibrate monotherapy and fenofibrate combined with exercise for improving metabolic syndrome and hepatic steatosis. METHODS: Thirty-four weeks old OLETF... -
- CITED
-
- Close
- SHARE
-
- Close
- Fenofibrate Reduces Age-related Hypercholesterolemia in Normal Rats on a Standard Diet
-
Han Y, Do MH, Kim MS, Seo E, Park MK, Kim DK, Lee HJ, Seo SY
- KMID: 1457672
- Korean J Physiol Pharmacol.
- 2010 Apr;14(2):77-81.
- doi: 10.4196/kjpp.2010.14.2.77
Plasma cholesterol is increased in normal aging in both rodents and humans. This is associated with reduced elimination of cholesterol and decreased receptor-mediated clearance of plasma low-density lipoprotein (LDL) cholesterol.... -
- CITED
-
- Close
- SHARE
-
- Close
- HDL Cholesterol Reduction during Rosiglitazone and Fenofibrate Treatment in a Type 2 Diabetes Mellitus Patient with Dyslipidemia
-
Im M, Kim M, Lee JK, Chang YH, Lee DY, Hong SI, Lee YY, Hong YJ
- KMID: 1096813
- Korean J Lab Med.
- 2010 Feb;30(1):17-19.
- doi: 10.3343/kjlm.2010.30.1.17
Thiazolidinediones (TZD), which are widely used as insulin sensitizers, and fibrates, which are lipid-lowering drugs, are used in the treatment of dyslipidemia that commonly accompanies diabetes. Several reports suggest elevated... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Xanthoma Presenting with Blepharoptosis
-
Shin CH, Woo KI, Chang HR
- KMID: 2206319
- J Korean Ophthalmol Soc.
- 2002 Dec;43(12):2585-2588.
PURPOSE: Xanthoma in the eyelids is a common dermatologic disorder. Generally these lesions do not affect the function of the eyelids. We report a case of xanthoma that has caused... -
- CITED
-
- Close
- SHARE
-
- Close
